Your browser is no longer supported. Please, upgrade your browser.
Settings
OTIC Otonomy, Inc. daily Stock Chart
OTIC [NASD]
Otonomy, Inc.
Index- P/E- EPS (ttm)-1.60 Insider Own0.28% Shs Outstand30.18M Perf Week5.02%
Market Cap69.41M Forward P/E- EPS next Y-1.48 Insider Trans0.00% Shs Float28.48M Perf Month-14.50%
Income-49.10M PEG- EPS next Q-0.46 Inst Own61.50% Short Float0.31% Perf Quarter-10.85%
Sales0.70M P/S99.16 EPS this Y44.70% Inst Trans0.21% Short Ratio2.50 Perf Half Y7.48%
Book/sh1.92 P/B1.20 EPS next Y12.90% ROA-47.20% Target Price8.33 Perf Year-22.03%
Cash/sh2.60 P/C0.89 EPS next 5Y20.40% ROE-65.90% 52W Range1.50 - 3.20 Perf YTD24.32%
Dividend- P/FCF- EPS past 5Y-9.70% ROI-55.10% 52W High-28.13% Beta2.42
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin-19.10% 52W Low53.33% ATR0.11
Employees49 Current Ratio7.30 Sales Q/Q100.00% Oper. Margin- RSI (14)37.55 Volatility5.01% 4.87%
OptionableYes Debt/Eq0.25 EPS Q/Q13.80% Profit Margin- Rel Volume0.77 Prev Close2.32
ShortableYes LT Debt/Eq0.25 EarningsAug 01 AMC Payout- Avg Volume35.13K Price2.30
Recom2.00 SMA20-8.13% SMA50-9.27% SMA200-5.39% Volume26,974 Change-0.86%
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-12-18Upgrade Piper Jaffray Neutral → Overweight
Aug-30-17Downgrade Piper Jaffray Overweight → Neutral
Aug-30-17Downgrade JP Morgan Overweight → Neutral
Aug-15-17Upgrade JP Morgan Neutral → Overweight
Jun-02-17Initiated Piper Jaffray Overweight $32
May-26-16Initiated WallachBeth Buy $29
Aug-10-15Upgrade Bernstein Mkt Perform → Outperform
May-22-15Downgrade JP Morgan Overweight → Neutral
Aug-03-19 06:52PM  Edited Transcript of OTIC earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-01-19 04:20PM  Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire -6.34%
Jul-25-19 04:05PM  Otonomy to Report Second Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Jul-11-19 12:33PM  Why Otonomy, Inc. (NASDAQ:OTIC) Is An Attractive Investment To Consider Simply Wall St.
Jun-12-19 08:00AM  Otonomy to Present at the Raymond James Life Sciences and MedTech Conference GlobeNewswire +5.96%
May-14-19 05:47AM  Edited Transcript of OTIC earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-06-19 06:35PM  Otonomy (OTIC) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:31PM  Otonomy: 1Q Earnings Snapshot Associated Press
04:17PM  Otonomy Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Otonomy, Inc. to Host Earnings Call ACCESSWIRE
May-02-19 09:00AM  Glenmark Therapeutics Expands Specialty Portfolio with OTIPRIO® Co-Promotion Agreement in the U.S. with Otonomy for Acute Otitis Externa Indication PR Newswire
07:30AM  Otonomy Announces OTIPRIO® Co-Promotion Agreement with Glenmark Therapeutics for Acute Otitis Externa Indication GlobeNewswire
May-01-19 07:30AM  Otonomy to Participate in SunTrust Robinson Humphrey Life Sciences Summit GlobeNewswire
Apr-29-19 04:05PM  Otonomy to Report First Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Apr-27-19 09:19AM  Do Institutions Own Otonomy, Inc. (NASDAQ:OTIC) Shares? Simply Wall St.
Apr-11-19 07:30AM  Otonomy Initiates Phase 1/2 Clinical Trial of OTO-313 in Tinnitus GlobeNewswire
Apr-04-19 09:57AM  The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy Zacks
Apr-03-19 09:16AM  Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy Zacks
Mar-11-19 06:46AM  Will Otonomy Continue to Surge Higher? Zacks +7.09%
Mar-08-19 04:39PM  Edited Transcript of OTIC earnings conference call or presentation 4-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-06-19 12:27PM  Those Who Purchased Otonomy Shares Three Years Ago Have A 84% Loss To Show For It Simply Wall St.
Mar-05-19 07:30AM  Otonomy to Participate in Two Upcoming Investor Conferences GlobeNewswire
Mar-04-19 04:18PM  Otonomy Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
Feb-25-19 04:05PM  Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update GlobeNewswire
Feb-13-19 07:55AM  Analysis: Positioning to Benefit within Apache, A. O. Smith, Diamondback Energy, Maiden, Lands' End, and Otonomy Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-06-19 07:30AM  Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting GlobeNewswire
Jan-23-19 12:22PM  An Examination Of Otonomy, Inc. (NASDAQ:OTIC) Simply Wall St.
Jan-03-19 07:30AM  Otonomy Provides Corporate and Product Pipeline Update GlobeNewswire
Jan-02-19 04:05PM  Otonomy to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Dec-07-18 02:10PM  Is Otonomy Inc (NASDAQ:OTIC) Excessively Paying Its CEO? Simply Wall St.
Nov-15-18 08:30AM  Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference GlobeNewswire
Nov-12-18 07:30AM  Report: Developing Opportunities within Control4, Nanometrics, Century Casinos, Steven Madden, Otonomy, and C&J Energy Services Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-06-18 07:30AM  Otonomy Presents Data Highlighting Potential of OTO-413, an Otic Sustained-Exposure Formulation of BDNF, to Treat Hearing Loss GlobeNewswire
Nov-05-18 09:09PM  Edited Transcript of OTIC earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
06:24PM  Otonomy: 3Q Earnings Snapshot Associated Press
04:12PM  Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-30-18 07:30AM  Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic" GlobeNewswire
Oct-29-18 07:30AM  Otonomy to Report Third Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Oct-18-18 07:20AM  Report: Exploring Fundamental Drivers Behind St. Joe, Emerge Energy Services LP, Resources Connection, FormFactor, Global Brass and Copper, and Otonomy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-02-18 07:30AM  Otonomy Announces OTIVIDEX Data Presentation at American Academy of Otolaryngology - Head and Neck Surgery Foundation Annual Meeting GlobeNewswire -5.12%
Sep-25-18 04:05PM  Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-19-18 04:51AM  Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors PR Newswire
Sep-18-18 01:57PM  Who Owns Otonomy Inc (NASDAQ:OTIC)? Simply Wall St.
Aug-28-18 08:30AM  Research Report Identifies Blue Apron, Otonomy, InnerWorkings, Rent-A-Center, NOW, and Flotek Industries with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-24-18 09:00AM  Are Options Traders Betting on a Big Move in Otonomy (OTIC) Stock? Zacks
Aug-08-18 06:15PM  Otonomy (OTIC) Reports Q2 Loss, Misses Revenue Estimates Zacks -10.90%
05:10PM  Otonomy: 2Q Earnings Snapshot Associated Press
04:22PM  Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Otonomy, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 07:30AM  Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication GlobeNewswire +13.64%
Aug-01-18 04:05PM  Otonomy to Report Second Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Jul-26-18 07:30AM  Otonomy Initiates Phase 3 Clinical Trial of OTIVIDEX in Ménières Disease GlobeNewswire
Jun-27-18 08:10AM  Consolidated Research: 2018 Summary Expectations for New York Community, Expedia, DowDuPont, Akamai Technologies, Energy Transfer Equity, and Otonomy Fundamental Analysis, Key Performance Indications GlobeNewswire -8.54%
May-29-18 07:20AM  Nektar Therapeutics and Three Additional Biotech Stocks on Our Research Desks Radar ACCESSWIRE
May-11-18 07:30AM  Report: Exploring Fundamental Drivers Behind Valvoline, KKR & Co., Otonomy, Radian Group, Red Rock Resorts, and Quest Diagnostics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +12.35%
May-09-18 05:51PM  Otonomy: 1Q Earnings Snapshot Associated Press
04:20PM  Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-02-18 07:30AM  Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Apr-09-18 10:07AM  Otonomy (OTIC) Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-19-18 12:45PM  Eeny, Meeny, Miny, Moe: JPMorgan Downgrades 4 Biotechs In Portfolio Rebalancing Benzinga -11.88%
Mar-08-18 04:41PM  Otonomy reports 4Q loss Associated Press
04:24PM  Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update GlobeNewswire
01:00PM  Otonomy, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 07:30AM  Otonomy to Present at Cowen and Company Health Care Conference GlobeNewswire
Mar-02-18 11:55AM  Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa GlobeNewswire
Mar-01-18 07:30AM  Otonomy to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update GlobeNewswire -5.04%
Feb-09-18 10:12AM  Otonomy Inc (NASDAQ:OTIC): Financial Strength Analysis Simply Wall St.
Feb-07-18 08:00AM  Report: Developing Opportunities within Discovery Communications, Otonomy, Marinus Pharmaceuticals, Citizens Financial Group, Washington Prime Group, and The Charles Schwab Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-06-18 07:30AM  Otonomy Announces Multiple Presentations for Hearing Loss and Tinnitus Programs at Upcoming Association for Research in Otolaryngology Meeting GlobeNewswire
Jan-09-18 07:30AM  Otonomy Provides Corporate and Product Pipeline Update GlobeNewswire
Jan-04-18 07:30AM  Otonomy to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Jan-02-18 09:20AM  Breakthrough drugs offer hope for the 360 million people with hearing loss CNBC +5.41%
Dec-28-17 12:36PM  ETFs with exposure to Otonomy, Inc. : December 28, 2017 Capital Cube +6.86%
Dec-27-17 08:54AM  Otonomy, Inc. :OTIC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Nov-27-17 04:30PM  Otonomy Announces Plan to Focus Resources on Development Programs GlobeNewswire
Nov-22-17 07:30AM  Otonomy to Present at Piper Jaffray Healthcare Conference GlobeNewswire
Nov-16-17 08:10AM  Market Trends Toward New Normal in Discovery Communications, Otonomy, Marinus Pharmaceuticals, Citizens Financial Group, Washington Prime Group, and Charles Schwab Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire +5.77%
Nov-10-17 10:16AM  Otonomy Gets Another Vote of Confidence from SunTrust SmarterAnalyst
08:10AM  Todays Research Reports on Stocks to Watch: Marinus Pharmaceuticals, Inc. and Otonomy, Inc. ACCESSWIRE
Nov-09-17 10:29AM  Otonomy Inc (OTIC) Sparks Optimism Among Investors; Heres Why SmarterAnalyst +83.04%
09:30AM  Sage Skyrockets on Postpartum Depression Drug Studies Data -- Biotech Movers TheStreet.com
09:20AM  Why Otonomy Shares Are Skyrocketing 24/7 Wall St.
Nov-08-17 06:10PM  Otonomy reports 3Q loss Associated Press
04:12PM  Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
04:05PM  Otonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX in Patients with Ménière's Disease GlobeNewswire
Nov-06-17 12:16PM  ETFs with exposure to Otonomy, Inc. : November 6, 2017 Capital Cube
Nov-01-17 04:05PM  Otonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update GlobeNewswire
Oct-03-17 07:01PM  Lifshitz & Miller LLP Announces Investigation of Alere Inc., Emergent BioSolutions, Inc., Frontier Communications Corporation, HSN, Inc., Insys Therapeutics Inc., LSB Industries, Inc. and Otonomy, Inc. PR Newswire
Sep-27-17 07:15PM  Bottom Fishing With Cash-Rich Biotechs GuruFocus.com
Sep-13-17 07:30AM  Otonomy Provides Business and Financial Update GlobeNewswire
Sep-05-17 05:16PM  OTONOMY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Otonomy, Inc. To Contact The Firm ACCESSWIRE -6.25%
Aug-31-17 07:56PM  ETFs with exposure to Otonomy, Inc. : August 31, 2017 Capital Cube
09:39AM  Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers TheStreet.com
Aug-30-17 04:51PM  Why Otonomy Inc (OTIC), Dycom Industries, Inc. (DY) and Mondelez International Inc (MDLZ) Are 3 of Todays Worst Stocks InvestorPlace -82.81%
04:18PM  Biotech Nears Zero On Dizzying Plunge After Failed Vertigo Trial Investor's Business Daily
04:07PM  Why H&R Block, Dycom Industries, and Otonomy Slumped Today Motley Fool
02:49PM  OTONOMY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Otonomy, Inc. To Contact The Firm Business Wire
12:33PM  Here's Why the Market Is Eviscerating Otonomy Inc. Stock Today Motley Fool
12:14PM  The Long and Short of Biotech Stocks The Wall Street Journal
11:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Otonomy, Inc. Business Wire
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. It also develops OTIVIDEX, a sustained-exposure formulation of the steroid dexamethasone in Phase III clinical trial for the treatment of Meniere's disease; OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase I/II clinical trial to treat tinnitus; and OTO-413, a proprietary formulation of brain-derived neurotrophic factor that is in Phase I/II clinical trial for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. In addition, the company develops OTO-510, a sustained-exposure formulation of small molecule otoprotectant for the prevention of cisplatin-induced hearing loss; and OTO-6XX induces hair cell regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation. Otonomy, Inc. was founded in 2008 and is headquartered in San Diego, California.